Skip to main navigation

Top bar

Biogen.com Information Request Sign up for Alerts Search

Investor Relations

Overview

News

Events Presentations

SEC Filings Annual Reports

Stock Quote & Chart Analyst Coverage Investor FAQs

Governance Documents Committee Composition & Charters Leadership Code of Business Conduct Contact the Board

News

News

News Category

Year

July 5, 2018

Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months

June 28, 2018

Biogen Exercises Option to Increase Ownership in Samsung Bioepis

June 25, 2018

Biogen to Report Second Quarter 2018 Financial Results on July 24, 2018

June 19, 2018

Biogen to Host Investor Webcast on Its Efforts Targeting Stroke on June 28, 2018

June 18, 2018

Biogen Foundation Selects Grantees to Receive $10 Million Investment for STEM Education

June 13, 2018

Samsung Bioepis and Biogen Announce Pooled Analysis Results of Anti-TNF Biosimilars BENEPALI™ (etanercept), FLIXABI™ (infliximab), and IMRALDI™ (adalimumab) at EULAR 2018

June 13, 2018

Biogen Enhances Commitment to SMA Research with Data Presented at Annual SMA Conference

June 7, 2018

Biogen Enters Exclusive Option Agreement to Acquire TMS’ Phase 2 Asset for Acute Stroke

June 4, 2018

Phase II Clinical Study of Elenbecestat Demonstrates Safety and Tolerability in MCI and Mild to Moderate Alzheimer's Disease at 18-Months

June 4, 2018

Biogen Announces Webcast of Annual Meeting of Stockholders

Pagination

First page
Previous page
…
Page 5
Page 6
Page 7
Page 8
Current page 9
Page 10
Page 11
Page 12
Page 13
…
Next page
Last page

Displaying 81 - 90 of 702

Footer

Investors
Careers
Our Stories
Contact Us

Follow us

Bottom

Privacy Policy
Terms & Conditions
Forward-Looking Statements
Community Guidelines

Investor Relations

Overview

News

Events & Presentations

Events
Presentations

Financials

SEC Filings
Annual Reports

Stock Information

Stock Quote & Chart
Analyst Coverage
Investor FAQs

Corporate Governance

Governance Documents
Committee Composition & Charters
Leadership
Code of Business Conduct
Contact the Board

Top bar

Biogen.com

Information Request

Sign up for Alerts

Search

Follow us